001     177020
005     20240419143147.0
024 7 _ |a 10.1038/s41467-021-26151-9
|2 doi
024 7 _ |a pmid:34642315
|2 pmid
024 7 _ |a altmetric:115117529
|2 altmetric
037 _ _ |a DKFZ-2021-02250
041 _ _ |a English
082 _ _ |a 500
100 1 _ |a Ferreiro-Iglesias, Aida
|0 0000-0002-1458-7936
|b 0
245 _ _ |a Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.
260 _ _ |a [London]
|c 2021
|b Nature Publishing Group UK
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1713529874_15505
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Although several oropharyngeal cancer (OPC) susceptibility loci have been identified, most previous studies lacked detailed information on human papillomavirus (HPV) status. We conduct a genome-wide analysis by HPV16 serology status in 4,002 oral cancer cases (OPC and oral cavity cancer (OCC)) and 5,256 controls. We detect four susceptibility loci pointing to a distinct genetic predisposition by HPV status. Our most notable finding in the HLA region, that is now confirmed to be specific of HPV(+)OPC risk, reveal two independent loci with strong protective effects, one refining the previously reported HLA class II haplotype association. Antibody levels against HPV16 viral proteins strongly implicate the protective HLA variants as major determinants of humoral response against L1 capsid protein or E6 oncoprotein suggesting a natural immune response against HPV(+)OPC promoted by HLA variants. This indicates that therapeutic vaccines that target E6 and attenuate viral response after established HPV infections might protect against HPV(+)OPC.
536 _ _ |a 316 - Infektionen, Entzündung und Krebs (POF4-316)
|0 G:(DE-HGF)POF4-316
|c POF4-316
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
700 1 _ |a McKay, James D
|b 1
700 1 _ |a Brenner, Nicole
|0 P:(DE-He78)b1326dc42cbbc5f92b10fe5f254f0bc2
|b 2
700 1 _ |a Virani, Shama
|0 0000-0002-1163-432X
|b 3
700 1 _ |a Lesseur, Corina
|0 0000-0001-6744-6750
|b 4
700 1 _ |a Gaborieau, Valerie
|b 5
700 1 _ |a Ness, Andy R
|b 6
700 1 _ |a Hung, Rayjean J
|0 0000-0002-4486-7496
|b 7
700 1 _ |a Liu, Geoffrey
|b 8
700 1 _ |a Diergaarde, Brenda
|b 9
700 1 _ |a Olshan, Andrew F
|b 10
700 1 _ |a Hayes, Neil
|0 0000-0001-6203-7771
|b 11
700 1 _ |a Weissler, Mark C
|b 12
700 1 _ |a Schroeder, Lea
|0 P:(DE-He78)b12aaacaa142dabed85c6d84d00bf0fb
|b 13
700 1 _ |a Bender, Noemi
|0 P:(DE-He78)540833b33724d8def638cce2f0b4e187
|b 14
700 1 _ |a Pawlita, Michael
|0 P:(DE-He78)d99bad949ba3ae93859eedae5ac266da
|b 15
700 1 _ |a Thomas, Steve
|b 16
700 1 _ |a Pring, Miranda
|b 17
700 1 _ |a Dudding, Tom
|0 0000-0003-3756-040X
|b 18
700 1 _ |a Kanterewicz, Beatriz
|b 19
700 1 _ |a Ferris, Robert
|b 20
700 1 _ |a Thomas, Sera
|b 21
700 1 _ |a Brhane, Yonathan
|b 22
700 1 _ |a Díez-Obrero, Virginia
|b 23
700 1 _ |a Milojevic, Maja
|0 0000-0002-8248-8884
|b 24
700 1 _ |a Smith-Byrne, Karl
|0 0000-0002-1932-7463
|b 25
700 1 _ |a Mariosa, Daniela
|0 0000-0001-8181-1419
|b 26
700 1 _ |a Johansson, Mattias J
|0 0000-0002-3116-5081
|b 27
700 1 _ |a Herrero, Rolando
|b 28
700 1 _ |a Boccia, Stefania
|b 29
700 1 _ |a Cadoni, Gabriella
|b 30
700 1 _ |a Lacko, Martin
|0 0000-0003-2868-4822
|b 31
700 1 _ |a Holcátová, Ivana
|b 32
700 1 _ |a Ahrens, Wolfgang
|b 33
700 1 _ |a Lagiou, Pagona
|b 34
700 1 _ |a Lagiou, Areti
|b 35
700 1 _ |a Polesel, Jerry
|0 0000-0001-9381-1520
|b 36
700 1 _ |a Simonato, Lorenzo
|b 37
700 1 _ |a Merletti, Franco
|b 38
700 1 _ |a Healy, Claire M
|b 39
700 1 _ |a Hansen, Bo T
|b 40
700 1 _ |a Nygård, Mari
|b 41
700 1 _ |a Conway, David I
|b 42
700 1 _ |a Wright, Sylvia
|b 43
700 1 _ |a Macfarlane, Tatiana V
|b 44
700 1 _ |a Robinson, Max
|0 0000-0003-4491-6865
|b 45
700 1 _ |a Alemany, Laia
|b 46
700 1 _ |a Agudo, Antonio
|b 47
700 1 _ |a Znaor, Ariana
|0 0000-0002-5849-4782
|b 48
700 1 _ |a Amos, Christopher I
|b 49
700 1 _ |a Waterboer, Tim
|0 P:(DE-He78)6b4ebb9791b983b5620c0caaf3468e30
|b 50
|e Last author
|u dkfz
700 1 _ |a Brennan, Paul
|0 0000-0002-0518-8714
|b 51
773 _ _ |a 10.1038/s41467-021-26151-9
|g Vol. 12, no. 1, p. 5945
|0 PERI:(DE-600)2553671-0
|n 1
|p 5945
|t Nature Communications
|v 12
|y 2021
|x 2041-1723
909 C O |p VDB
|o oai:inrepo02.dkfz.de:177020
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)b1326dc42cbbc5f92b10fe5f254f0bc2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 13
|6 P:(DE-He78)b12aaacaa142dabed85c6d84d00bf0fb
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 14
|6 P:(DE-He78)540833b33724d8def638cce2f0b4e187
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 15
|6 P:(DE-He78)d99bad949ba3ae93859eedae5ac266da
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 50
|6 P:(DE-He78)6b4ebb9791b983b5620c0caaf3468e30
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-316
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Infektionen, Entzündung und Krebs
|x 0
914 1 _ |y 2021
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NAT COMMUN : 2019
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2021-02-02
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Peer review
|d 2021-02-02
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1150
|2 StatID
|b Current Contents - Physical, Chemical and Earth Sciences
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1060
|2 StatID
|b Current Contents - Agriculture, Biology and Environmental Sciences
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1040
|2 StatID
|b Zoological Record
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-02-02
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2021-02-02
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b NAT COMMUN : 2019
|d 2021-02-02
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2021-02-02
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2021-02-02
920 1 _ |0 I:(DE-He78)F022-20160331
|k F022
|l Infektionen und Krebs-Epidemiologie
|x 0
920 1 _ |0 I:(DE-He78)F020-20160331
|k F020
|l Infektionen und Krebs-Epidemiologie
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)F022-20160331
980 _ _ |a I:(DE-He78)F020-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21